Incyte to Present at the 9th Annual JMP Securities Healthcare Conference

  Incyte to Present at the 9th Annual JMP Securities Healthcare Conference  JMP Securities Healthcare Conference 2014  Business Wire  WILMINGTON, Del. -- June 12, 2014  Incyte Corporation (Nasdaq:INCY) announced today it will present at the 9^th Annual JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 11:00 a.m. (EDT) in New York.  The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.  Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.  Contact:  Incyte Corporation Pamela M. Murphy Vice President, Investor Relations & Corporate Communications 302-498-6944